- Home
- PBYI vs NUTX Comparison
PBYI vs NUTX Comparison
Compare PBYI & NUTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- NUTX
- Stock Information
- Founded
- PBYI 2010
- NUTX 2011
- Country
- PBYI United States
- NUTX United States
- Employees
- PBYI N/A
- NUTX N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- NUTX Retail: Computer Software & Peripheral Equipment
- Sector
- PBYI Health Care
- NUTX Technology
- Exchange
- PBYI Nasdaq
- NUTX Nasdaq
- Market Cap
- PBYI 126.5M
- NUTX 104.2M
- IPO Year
- PBYI N/A
- NUTX N/A
- Fundamental
- Price
- PBYI $2.42
- NUTX $28.70
- Analyst Decision
- PBYI Strong Buy
- NUTX Strong Buy
- Analyst Count
- PBYI 1
- NUTX 2
- Target Price
- PBYI $7.00
- NUTX $55.00
- AVG Volume (30 Days)
- PBYI 524.8K
- NUTX 71.6K
- Earning Date
- PBYI 11-07-2024
- NUTX 11-07-2024
- Dividend Yield
- PBYI N/A
- NUTX N/A
- EPS Growth
- PBYI 492.79
- NUTX N/A
- EPS
- PBYI 0.47
- NUTX N/A
- Revenue
- PBYI $243,569,000.00
- NUTX $292,000,390.00
- Revenue This Year
- PBYI N/A
- NUTX $22.25
- Revenue Next Year
- PBYI N/A
- NUTX $17.37
- P/E Ratio
- PBYI $5.20
- NUTX N/A
- Revenue Growth
- PBYI 6.30
- NUTX 26.02
- 52 Week Low
- PBYI $2.23
- NUTX $4.16
- 52 Week High
- PBYI $7.73
- NUTX $39.45
- Technical
- Relative Strength Index (RSI)
- PBYI 36.08
- NUTX 54.47
- Support Level
- PBYI $2.83
- NUTX $25.86
- Resistance Level
- PBYI $3.25
- NUTX $38.00
- Average True Range (ATR)
- PBYI 0.29
- NUTX 4.06
- MACD
- PBYI -0.04
- NUTX 0.50
- Stochastic Oscillator
- PBYI 6.03
- NUTX 43.47
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About NUTX Nutex Health Inc.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.